Connect with us

Health

First-of-Its-Kind Alzheimer’s Vaccine Just Passed Safety Tests in Latest Human Trials – ScienceAlert

A first-of-its-kind experimental vaccine designed to protect against Alzheimer’s disease has passed the latest stage of human…

Published

on

Article feature image

A first-of-its-kind experimental vaccine designed to protect against Alzheimer’s disease has passed the latest stage of human trials, scientists report in a new study.
In a phase II clinical trial, the drug candidate AADvac1, developed by biotech company…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Emphasize personal health benefits of COVID-19 vaccination, experts say – Science Daily
Article feature image
Black American women with vitamin D insufficiency more likely to test positive for COVID-19, study finds – Science Daily